Investigation of Structure-Activity Relationships of Dexrazoxane Analogs Reveals Topoisomerase IIβ Interaction as a Prerequisite for Effective Protection against Anthracycline Cardiotoxicity

Bisdioxopiperazine agent dexrazoxane (ICRF-187) has been the only effective and approved drug for prevention of chronic anthracycline cardiotoxicity. However, the structure-activity relationships (SARs) of its cardioprotective effects remain obscure owing to limited investigation of its derivatives/...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of pharmacology and experimental therapeutics 2020-06, Vol.373 (3), p.402-415
Hauptverfasser: Kollárová-Brázdová, Petra, Jirkovská, Anna, Karabanovich, Galina, Pokorná, Zuzana, Bavlovič Piskáčková, Hana, Jirkovský, Eduard, Kubeš, Jan, Lenčová-Popelová, Olga, Mazurová, Yvona, Adamcová, Michaela, Skalická, Veronika, Štěrbová-Kovaříková, Petra, Roh, Jaroslav, Šimůnek, Tomáš, Štěrba, Martin
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!